# | Title | Journal | Year | Citations |
---|
1 | T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial | Lancet, The | 2015 | 2,476 |
2 | Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment | Science | 2013 | 1,715 |
3 | A human memory T cell subset with stem cell–like properties | Nature Medicine | 2011 | 1,547 |
4 | Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent | Science | 1996 | 1,433 |
5 | Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus | Hepatology | 1990 | 1,249 |
6 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens | Journal of Clinical Oncology | 2008 | 1,210 |
7 | Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance | Advances in Immunology | 1999 | 998 |
8 | HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors | Proceedings of the National Academy of Sciences of the United States of America | 2000 | 910 |
9 | High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin | Nature Medicine | 2007 | 743 |
10 | The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures | Immunity | 2013 | 700 |
11 | The Patient Experience and Health Outcomes | New England Journal of Medicine | 2013 | 655 |
12 | High-fidelity mRNA amplification for gene profiling | Nature Biotechnology | 2000 | 650 |
13 | The Incidence of Transfusion-Associated Hepatitis G Virus Infection and Its Relation to Liver Disease | New England Journal of Medicine | 1997 | 610 |
14 | Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients | Journal of Immunotherapy | 2003 | 598 |
15 | Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection | New England Journal of Medicine | 1996 | 596 |
16 | NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis | Nature | 2016 | 552 |
17 | Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis | Hepatology | 1991 | 537 |
18 | Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood | Lancet, The | 1999 | 525 |
19 | Tumour immunity: effector response to tumour and role of the microenvironment | Lancet, The | 2008 | 476 |
20 | Red blood cell transfusion in clinical practice | Lancet, The | 2007 | 426 |
21 | The dual role of IL-10 | Trends in Immunology | 2003 | 413 |
22 | MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18 | Journal of Experimental Medicine | 2010 | 382 |
23 | Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo | Gastroenterology | 2007 | 372 |
24 | Progression of fibrosis in chronic hepatitis C | Gastroenterology | 2003 | 368 |
25 | Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells | Nature Medicine | 2005 | 366 |
26 | Interleukin-10 and the immune response against cancer: a counterpoint | Journal of Leukocyte Biology | 2005 | 329 |
27 | A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 307 |
28 | Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells | NMR in Biomedicine | 2005 | 295 |
29 | Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study | Hepatology | 2001 | 286 |
30 | The hazards of blood transfusion in historical perspective | Blood | 2008 | 285 |
31 | Platelet transfusions | Lancet, The | 2007 | 276 |
32 | Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies | Blood | 2016 | 274 |
33 | Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2 | Human Gene Therapy | 2002 | 261 |
34 | Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology | 2005 | 240 |
35 | Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA | Lancet, The | 2003 | 239 |
36 | Increased Vaccine-Specific T Cell Frequency After Peptide-Based Vaccination Correlates with Increased Susceptibility to In Vitro Stimulation But Does Not Lead to Tumor Regression | Journal of Immunology | 1999 | 214 |
37 | Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell–depleted stem cell transplantation | Blood | 2015 | 200 |
38 | Suppression of HCV-specific T cells without differential hierarchy demonstrated in persistent HCV infection | Hepatology | 2003 | 199 |
39 | Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes | Molecular and Biochemical Parasitology | 1994 | 197 |
40 | Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression | Journal of Immunology | 1999 | 196 |
41 | Tumors as elusive targets of T-cell-based active immunotherapy | Trends in Immunology | 2003 | 187 |
42 | Blood collection and transfusion in the United States in 2001 | Transfusion | 2007 | 185 |
43 | Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation | Blood | 2001 | 182 |
44 | Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors | Proceedings of the National Academy of Sciences of the United States of America | 2010 | 181 |
45 | Variant Genotypes of the Low-Affinity Fcγ Receptors in Two Control Populations and a Review of Low-Affinity Fcγ Receptor Polymorphisms in Control and Disease Populations | Blood | 1999 | 175 |
46 | Quantitative real-time PCR: a powerful ally in cancer research | Trends in Molecular Medicine | 2003 | 174 |
47 | Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved Survival | Biology of Blood and Marrow Transplantation | 2007 | 174 |
48 | Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study | Aids | 2000 | 173 |
49 | Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma | Science | 1991 | 170 |
50 | Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia | Leukemia | 2007 | 167 |